Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > C-MET

C-MET

Brief Information

Name:Hepatocyte growth factor receptor
Target Synonym:EC 2.7.10,EC:2.7.10.1,HGF receptor,HGF/SF receptor,Hepatocyte growth factor receptor,Tyrosine-protein kinase Met,MET,SF receptor,Scatter factor receptor,MET Proto-Oncogene, Receptor Tyrosine Kinase,Proto-Oncogene C-Met,Met Proto-Oncogene,EC 2.7.10.1,DFNB97,AUTS9,RCCP2,C-Met,HGFR,Proto-Oncogene Proteins c-met
Number of Launched Drugs:11
Number of Drugs in Clinical Trials:65
Lastest Research Phase:Phase 3 Clinical

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Envonalkib TQ-B3139; CT-1139; CT-711 Approved Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd 安洛晴 Mainland China Carcinoma, Non-Small-Cell Lung Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group 2024-06-11 Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Crizotinib PF-1066; PF-2341066; PF-02341066; PF-002341066 Approved Pfizer Inc 赛可瑞, Xalkori United States Carcinoma, Non-Small-Cell Lung Pf Prism Cv 2011-08-26 Urethral Neoplasms; Neoplasm Metastasis; Adenocarcinoma; Neurilemmoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Granuloma, Plasma Cell; Endometrial Neoplasms; Lymphoma, Large-Cell, Anaplastic; Lymphoma; Ureteral Neoplasms; Solid tumours; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Neuroblastoma; Urinary Bladder Neoplasms; Myofibroma; Uveal melanoma; Multiple Myeloma; Neurofibromatosis 2; Neoplasms; Renal Insufficiency; Hematologic Neoplasms Details
Unecritinib TQ-B3101; TTQ-B3101 Approved Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Southeast University 安柏尼 Mainland China Carcinoma, Non-Small-Cell Lung Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd 2024-04-24 Stomach Neoplasms; Neoplasms; Lymphoma, Large-Cell, Anaplastic; Lymphoma; Carcinoma, Non-Small-Cell Lung Details
Glumetinib HH-SCC244; SCC244; SCC-244 Approved Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences, ShangHai HaiHe Biopharma Co Ltd 海益坦, Haiyitan Mainland China Carcinoma, Non-Small-Cell Lung ShangHai HaiHe Biopharma Co Ltd 2023-03-07 Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Tepotinib hydrochloride hydrate MSC-2156119J; MSC-2156119; EMD-1214063 Approved Merck Serono Tepmetko, テプミトコ, TEPMETKO Japan Carcinoma, Non-Small-Cell Lung Merck KGaA, Darmstadt, Germany 2020-03-25 Solid tumours; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
Capmatinib Hydrochloride INCB-28060; C2A374O70X; INC-280; INCB-028060; NVP-INC280-NX Approved Incyte Corp, Novartis Pharma Ag Tabrecta United States Carcinoma, Non-Small-Cell Lung Novartis Pharmaceuticals Corp 2020-05-06 Adenocarcinoma of Lung; Neoplasm Metastasis; Carcinoma, Hepatocellular; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Gliosarcoma; Colorectal Neoplasms; Sarcoma; Solid tumours; Neoplasms; Triple Negative Breast Neoplasms; Glioblastoma; Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms; Liver Neoplasms Details
Savolitinib HM-5016504; AZD-6094; HMP-504; HMPL-504 Approved Hutchison Medipharma Ltd 沃瑞沙, ORPATHYS Mainland China Carcinoma, Non-Small-Cell Lung Hutchison Medipharma Ltd 2021-06-22 Central Nervous System Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carcinoma, Squamous Cell; Glioma; Urologic Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Diffuse Intrinsic Pontine Glioma; Cholangiocarcinoma; Medulloblastoma; Kidney Diseases; Neoplasms; Colonic Neoplasms; Carcinoma; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Rectal Neoplasms; Kidney Neoplasms; Solid tumours Details
Ensartinib Hydrochloride X-396 Approved Xcovery 贝美纳, ENSACOVE Mainland China Carcinoma, Non-Small-Cell Lung Betta Pharmaceuticals Co Ltd 2020-11-17 Neuroblastoma; Xanthogranuloma, Juvenile; Neuroectodermal Tumors, Primitive, Peripheral; Neoplasms, Germ Cell and Embryonal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Lymphoma, Non-Hodgkin; Lung Neoplasms; Glioma; Brain metastases; Histiocytic Sarcoma; Sarcoma, Ewing; Solid tumours; Osteosarcoma; Histiocytosis, Langerhans-Cell; Sarcoma; Central Nervous System Neoplasms; Neoplasms; Wilms Tumor; Rhabdoid Tumor; Hepatoblastoma; Medulloblastoma; Ependymoma; Rhabdomyosarcoma Details
Amivantamab JNJ-61186372; JNJ-372; JNJ-6372; CNTO4424; CNTO-4424 Approved Genmab A/S, Johnson & Johnson Innovative Medicine RYBREVANT United States Carcinoma, Non-Small-Cell Lung Janssen Biotech Inc 2021-05-21 Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Glioblastoma; Carcinoma, Adenoid Cystic; Colorectal Neoplasms; Lung Neoplasms; Glioma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Carcinoma, Hepatocellular Details
Cabozantinib S-malate XL-184; BMS-907351; RO7047650; RO-7047650 Approved Exelixis Inc Cometriq, Cabometyx United States Thyroid Neoplasms; Carcinoma, Neuroendocrine Exelixis Inc 2012-11-29 Neuroblastoma; Thyroid Neoplasms; Hepatic Insufficiency; Astrocytoma; Peritoneal Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Gliosarcoma; Urethral Neoplasms; Sarcoma, Clear Cell; Uterine Neoplasms; Cholangiocarcinoma; Neurofibroma, Plexiform; Brain Neoplasms; Adenocarcinoma, Clear Cell; Carcinoma, Adenosquamous; Medullary thyroid cancer (MTC); Sarcoma, Ewing; Sarcoma; Osteosarcoma; Sarcoma, Alveolar Soft Part; Meningioma; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Thyroid Cancer, Papillary; Paraganglioma; Neoplasms, Germ Cell and Embryonal; Carcinoma, Hepatocellular; Prostatic Neoplasms; Glioma; Brain metastases; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Squamous Cell; Lymphoma; Carcinoma, Neuroendocrine; Fallopian Tube Neoplasms; Carcinoma, Renal Cell; Adenoma, Islet Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Renal Insufficiency; Hepatoblastoma; Pheochromocytoma; Carcinoid Tumor; Carcinoma, Merkel Cell; Rejection of liver transp Details
Vebreltinib PLB-1001; CBT-101; APL-101; CBI-3103 Approved Mainland China Carcinoma, Non-Small-Cell Lung Beijing Purunao Biotechnology Co Ltd 2023-11-16 Colonic Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Glioma; Thyroid Neoplasms; Lung Neoplasms; Hepatic Insufficiency; Astrocytoma; Brain Neoplasms; Solid tumours; Glioblastoma; Pancreatic Neoplasms; Ganglioglioma; Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms; Kidney Neoplasms Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
HS-10241 HS-10241 Phase 3 Clinical Jiangsu Hansoh Pharmaceutical Group Co Ltd Solid tumours; Carcinoma; Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Zanzalintinib XL-092 Phase 3 Clinical Exelixis Inc Solid tumours; Leiomyosarcoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Carcinoma, Transitional Cell; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Colorectal Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
Fosgonimeton NDX-1017; ATH-1017; ATH 1017 Phase 3 Clinical M3 Biotechnology Alzheimer Disease; Dementia; Parkinson Disease; Lewy Body Disease Details
Sitravatinib MGCD-516; IND-155305; MGCD-0516; MG-91516; MG-516 Phase 3 Clinical Mirati Therapeutics Inc Breast Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Endometrial Neoplasms; Lung Neoplasms; Metastatic breast cancer; Esophageal Squamous Cell Carcinoma; Mouth Neoplasms; Carcinoma, Squamous Cell; Hepatic Insufficiency; Ureteral Neoplasms; Solid tumours; Lung Diseases; Liposarcoma; Uveal melanoma; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Carcinoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Kidney Neoplasms; Biliary Tract Neoplasms Details
HS-20117 HS-20117; PM1080; PM-1080 Phase 3 Clinical Solid tumours; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Telisotuzumab adizutecan ABBV-400 Phase 3 Clinical Abbvie Inc Solid tumours; Biliary Tract Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Esophageal adenocarcinoma; Carcinoma, Pancreatic Ductal; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
SC-0011 SC-0011 Phase 3 Clinical Shijiazhuang Zhikang Hongren New Drug Development Co Ltd Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung Details
AL-2846 AL-2846 Phase 3 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Advenchen Laboratories Nanjing Ltd Neurofibromatoses; Neurilemmoma; Neurofibromatosis 1; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Thyroid Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms; Medullary thyroid cancer (MTC); Solid tumours; Neurofibroma; Ganglioglioma; Pancreatic Neoplasms; Neoplasms; Stomach Neoplasms; Ovarian Neoplasms; Liver Neoplasms; Bone metastases Details
Ningetinib Tosylate CT-053-PTSA; CT-053 Phase 2 Clinical Hec Pharm Co Ltd Solid tumours; Intestinal Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Pamvatamig MCLA-129 Phase 2 Clinical Merus Nv Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung Details
Merestinib 5OGS5K699E; LY-2801653 Phase 2 Clinical Eli Lilly And Company Biliary Tract Neoplasms; Solid tumours; Skin Melanoma; Bone metastases; Pancreatic Neoplasms; Neoplasms; Microsatellite instability-high cancer; Breast Neoplasms; Cholangiocarcinoma; Lymphoma, Mantle-Cell; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung Details
Sym-015 Sym-015 Phase 2 Clinical Symphogen A/S Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Vabametkib KDDF-201603-08; ABN-401 Phase 2 Clinical Abion Inc Solid tumours; Neoplasms Details
REGN-5093-M114 METxMET-M114; REGN5093-M114 Phase 2 Clinical Regeneron Pharmaceuticals Inc Carcinoma, Non-Small-Cell Lung Details
Bafisontamab FIT-013a; EMB-01 Phase 2 Clinical Shanghai Epimab Biotherapeutics, Inc Biliary Tract Neoplasms; Liver Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms Details
GB-263 GB-263; GB-263T Phase 2 Clinical Genor Biopharma Co Ltd Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Elzovantinib TPX-0022 Phase 2 Clinical Turning Point Therapeutics Inc Solid tumours; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung Details
PRO-1286 PRO-1286; GEN1286; GEN-1286 Phase 2 Clinical ProfoundBio (Suzhou) Co Ltd Solid tumours; Neoplasms Details
Do-1 Do-1 Phase 2 Clinical DeuterOncology NV Lung Neoplasms Details
PFL-002 VERT-002; PFL-002; PFL-002/VERT-002 Phase 2 Clinical Vertical Bio AG Solid tumours; Carcinoma, Non-Small-Cell Lung Details
EMI-137 EMI-137; GE-137 Phase 2 Clinical Ge Healthcare Esophageal Neoplasms; Extranodal Extension; Colonic Neoplasms; Barrett Esophagus Details
Davutamig REGN-5093 Phase 2 Clinical Regeneron Pharmaceuticals Inc Carcinoma, Non-Small-Cell Lung Details
CKD-702 Phase 2 Clinical Chong Kun Dang Pharmaceutical Corp Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Recombinant adenovirus-hepatocyte growth factor(Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences) Phase 2 Clinical Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences, Beijing Haitai United Pharmaceutical Technology Development Co Ltd Myocardial Ischemia Details
RC-108 RC-108; RC108 Phase 2 Clinical RemeGen Co Ltd Solid tumours; Digestive System Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Emibetuzumab LA-480; LY-2875358 Phase 2 Clinical Eli Lilly And Company Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Lymphoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
SHR-A1403 SHR-A1403 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd Solid tumours Details
E-3112 E-3112; E-3112/CP1 Phase 1 Clinical Ea Pharma Liver Diseases Details
CM-118 CM-118 Phase 1 Clinical Xcovery Neoplasms; Carcinoma, Non-Small-Cell Lung Details
Kanitinib CX-1003 Phase 1 Clinical Beijing Konruns Pharmaceutical Co Ltd, Guangzhou Yingsheng Bio Technology Co Ltd Solid tumours Details
BPI-9016 BPI-9016; BPI-9016M Phase 1 Clinical Betta Pharmaceuticals Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
HLX-55 HLX-55; KTN-0216 Phase 1 Clinical Kolltan Pharmaceuticals Inc Solid tumours Details
Pamufetinib TAS-115 Phase 1 Clinical Taiho Pharmaceutical Co Ltd, Otsuka Pharmaceutical Co Ltd Neoplasms Details
NP-01 (SSY Group) Phase 1 Clinical Solid tumours; Liver Neoplasms; Stomach Neoplasms; Prostatic Neoplasms; Lung Neoplasms Details
Ad-NK4 gene therapy (Chiba Cancer Center Res Inst/Toho University/Tokyo Women’s Medical University Yachiyo Medical Center) Phase 1 Clinical Mesothelioma Details
Boxitinib Hydrochloride Phase 1 Clinical Hec Pharm Co Ltd Carcinoma, Renal Cell; Stomach Neoplasms; Breast Neoplasms; Glioma; Lung Neoplasms Details
BYON-3521 BYON-3521 Phase 1 Clinical Byondis Bv Solid tumours; Neoplasms Details
ATH-1020 ATH-1020 Phase 1 Clinical Athira Pharma Inc Details
QBH-196 QBH-196 Phase 1 Clinical Shenyang Pharmaceutical University Solid tumours; Stomach Neoplasms Details
BG-T187 BG-T187; BGT187 Phase 1 Clinical BeOne Medicines Ltd Solid tumours; Lung Neoplasms; Gastrointestinal Neoplasms Details
KY-0301 KY-0301 Phase 1 Clinical Novatim Immune Therapeutics (Zhejiang) Co Ltd Solid tumours Details
[11C]savolitinib [11C]savolitinib Phase 1 Clinical Astrazeneca Plc Details
[14C]HS-10241 [14C]HS-10241 Phase 1 Clinical Jiangsu Hansoh Pharmaceutical Group Co Ltd Carcinoma, Non-Small-Cell Lung Details
YL-211 YL211; YL-211; RG-6648; RG6648 Phase 1 Clinical MediLink Therapeutics Co Ltd Solid tumours Details
ABBV-303 ABBV-303; DF-4101 Phase 1 Clinical Dragonfly Therapeutics Llc Solid tumours Details
FPI-2107 [111In]-FPI-2107 Phase 1 Clinical Fusion Pharmaceuticals Inc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung Details
FPI-2053 FPI-2053 Phase 1 Clinical Fusion Pharmaceuticals Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung Details
DM-005 DM005; YH013; DM-005 Phase 1 Clinical Doma Biopharmaceutical (Suzhou) Co Ltd Solid tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung Details
ANS-014004 ANS014004; ANS-014004; ANS-01; ANS01 Phase 1 Clinical Solid tumours; Neoplasms Details
FPI-2068 [225Ac]-FPI-2068; FPI-2068 Phase 1 Clinical Fusion Pharmaceuticals Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung Details
SPH-3348 SPH-3348; SPH3348; I-020 Phase 1 Clinical Shanghai Pharmaceuticals Holding Co Ltd Solid tumours; Neoplasms Details
MYTX-011 MYTX-011 Phase 1 Clinical Mythic Therapeutics Inc Carcinoma, Non-Small-Cell Lung Details
AZD9592 AZD-9592; AZD9592 Phase 1 Clinical Astrazeneca Plc Solid tumours; Head and Neck Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
ATH-1105 ATH-1105 Phase 1 Clinical Athira Pharma Inc Amyotrophic Lateral Sclerosis; Frontotemporal Dementia Details
TAVO-412 TAVO-412 Phase 1 Clinical Tavotek Biotherapeutics (Hong Kong) Ltd, Tuochuang Biotechnology (Jiangsu) Co Ltd Solid tumours; Neoplasms Details
NP-107 NP107; NP-107 Phase 1 Clinical Shanghai Nawei Biotechnology Co Ltd Solid tumours Details
ASKC-202 ASKC202 Phase 1 Clinical Jiangsu Aosaikang Pharmaceutical Co Ltd Solid tumours; Carcinoma, Non-Small-Cell Lung Details
LMV-12(HE003) LMV-12(HE003) Phase 1 Clinical Nanchang Hongyi Technology Co Ltd Solid tumours Details
GST-HG161 GST-HG161 Phase 1 Clinical Wuxi Apptec Co Ltd, Fujian Cosunter Pharmaceutical Co Ltd Solid tumours; Neoplasms; Carcinoma, Hepatocellular Details
Metatinib Trometamol BMS-817378; SIM-817378 Phase 1 Clinical Bristol-Myers Squibb Company Solid tumours; Liver Neoplasms; Stomach Neoplasms; Colorectal Neoplasms Details
NP-01 (Shijiazhuang No.4 Pharmaceutical/Nanjing Nadingfei Medical Technology) NP-01 Phase 1 Clinical Shijiazhuang No 4 Pharmaceutical Co Ltd, Nanjing Nadingfei Pharmaceutical Technology Co Ltd Liver Neoplasms; Solid tumours; Stomach Neoplasms; Lung Neoplasms Details
SAIT-301 SAIT-301 Phase 1 Clinical Samsung Medical Center Neoplasms Details
NPS-1034 HOPE-777; KDDF-201111-02 Neopharma Ltd Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message